[go: up one dir, main page]

AU4017695A - Ruthenium complexes and their use as immunosuppressive agents - Google Patents

Ruthenium complexes and their use as immunosuppressive agents

Info

Publication number
AU4017695A
AU4017695A AU40176/95A AU4017695A AU4017695A AU 4017695 A AU4017695 A AU 4017695A AU 40176/95 A AU40176/95 A AU 40176/95A AU 4017695 A AU4017695 A AU 4017695A AU 4017695 A AU4017695 A AU 4017695A
Authority
AU
Australia
Prior art keywords
immunosuppressive agents
ruthenium complexes
ruthenium
complexes
immunosuppressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40176/95A
Inventor
Cecilia M Bastos
Timothy D Ocain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procept Inc
Original Assignee
Procept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/331,388 external-priority patent/US5512687A/en
Priority claimed from US08/482,308 external-priority patent/US5708022A/en
Application filed by Procept Inc filed Critical Procept Inc
Publication of AU4017695A publication Critical patent/AU4017695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C07F15/0053—Ruthenium compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40176/95A 1994-10-28 1995-10-30 Ruthenium complexes and their use as immunosuppressive agents Abandoned AU4017695A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US33120494A 1994-10-28 1994-10-28
US331388 1994-10-28
US08/331,388 US5512687A (en) 1994-10-28 1994-10-28 Compounds for inhibiting immune response
US331204 1994-10-28
US47252595A 1995-06-07 1995-06-07
US08/482,308 US5708022A (en) 1994-10-28 1995-06-07 Method for inhibiting immune response
US482308 1995-06-07
US472525 1995-06-07
PCT/US1995/014067 WO1996013510A1 (en) 1994-10-28 1995-10-30 Ruthenium complexes and their use as immunosuppressive agents

Publications (1)

Publication Number Publication Date
AU4017695A true AU4017695A (en) 1996-05-23

Family

ID=27502438

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40176/95A Abandoned AU4017695A (en) 1994-10-28 1995-10-30 Ruthenium complexes and their use as immunosuppressive agents

Country Status (2)

Country Link
AU (1) AU4017695A (en)
WO (1) WO1996013510A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030790A1 (en) 1999-10-27 2001-05-03 The University Court, The University Of Edinburgh Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
GB0016052D0 (en) 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds
EP1687021B1 (en) * 2003-11-20 2013-11-06 Boehringer Ingelheim International GmbH Method of removing transition metals, especially from metathesis reaction products
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2007089929A2 (en) * 2006-01-31 2007-08-09 E. Heller & Company Osmium compounds for treatment of psoriasis
EP2032701B1 (en) 2006-06-23 2013-11-27 Alethia Biotherapeutics Inc. Polynucleotides and polypeptides involved in cancer
GB0711849D0 (en) 2007-06-19 2007-07-25 Oxford Biosensors Ltd Redox Mediators
MX336869B (en) 2008-11-03 2016-02-04 Alethia Biotherapeutics Inc Antibodies that specifically block the biological activity of a tumor antigen.
CN106146664B (en) 2011-03-31 2021-09-07 Adc治疗股份有限公司 Antibodies against kidney-associated antigen 1 and antigen-binding fragments thereof
PL2802351T3 (en) 2012-01-09 2019-11-29 Adc Therapeutics Sa Agents for treating triple negative breast cancer
GB201507452D0 (en) 2015-04-30 2015-06-17 Inside Biometrics Ltd Electron transfer agent
CN116874533B (en) * 2023-01-20 2024-12-20 南通大学 Bipyridine/phenanthroline ruthenium complex and its preparation method and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000905A1 (en) * 1984-07-24 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Ruthenium compounds having a tumor inhibiting activity
EP0188585A1 (en) * 1984-07-24 1986-07-30 Byk Gulden Lomberg Chemische Fabrik GmbH Ruthenium compositions having a tumor inhibiting activity
US4699978A (en) * 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
JPH04182432A (en) * 1990-11-19 1992-06-30 Toshio Tanaka Calcium-dependent cyclic nucleotide phosphodiesterase inhibitor
US5238689A (en) * 1992-01-07 1993-08-24 Procept, Inc. Use of ruthenium red as immunosuppressive agents

Also Published As

Publication number Publication date
WO1996013510A1 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
AU2263295A (en) Contrast agents
AU1315797A (en) Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
AU1573595A (en) Multi-purpose convertible furniture
AU4190496A (en) Multi-purpose quarters
AU4017695A (en) Ruthenium complexes and their use as immunosuppressive agents
AU4268496A (en) Targeting complexes and use thereof
AU4343496A (en) Folding chair
AU3554995A (en) Antipicornaviral agents
AU3634595A (en) Bis-oxazolidines and their use
AU7677194A (en) Sulfamethoxazole-specific immunosuppressive agents
AU1614495A (en) Chair
AU3290197A (en) Halopropargyl inclusion complexes
AU3784695A (en) Immunosuppressive cyclolignan derivatives
AU2520195A (en) Desk structure
AU5002196A (en) Immunosuppressive agents
AU3052195A (en) Hemopoietic function-stimulating agent
AU3533095A (en) Arylthiadiazole derivative and antiviral agent containing the same
AU4766293A (en) Arrangement in supporting legs
AU644999B3 (en) Improvements in furniture
AU3464695A (en) Multi-purpose pan-stove
AU4416296A (en) Mel-cam ligand and its use
AU7423196A (en) Improvements in cots
ZA9410172B (en) Metallocenes and their use as catalysts
AU2858195A (en) Seat
AU649393B3 (en) Improvements in chairs